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Abstract
Background Temperature management is used with increased 
frequency as a tool to mitigate neurological injury. Although 
frequently used, little is known about the optimal cooling 
methods for inducing and maintaining controlled normo- and 
hypothermia in the intensive care unit (ICU). In this study we 
compared the efficacy of several commercially available cooling 
devices for temperature management in ICU patients with 
various types of neurological injury.
Methods Fifty adult ICU patients with an indication for 
controlled mild hypothermia or strict normothermia were 
prospectively enrolled. Ten patients in each group were 
assigned in consecutive order to conventional cooling (that is, 
rapid infusion of 30 ml/kg cold fluids, ice and/or coldpacks), 
cooling with water circulating blankets, air circulating blankets, 
water circulating gel-coated pads and an intravascular heat 
exchange system. In all patients the speed of cooling (expressed 
as°C/h) was measured. After the target temperature was 
reached, we measured the percentage of time the patient's 
temperature was 0.2°C below or above the target range. Rates
of temperature decline over time were analyzed with one-way 
analysis of variance. Differences between groups were analyzed 
with one-way analysis of variance, with Bonferroni correction for 
multiple comparisons. A p <  0.05 was considered statistically 
significant.
Results Temperature decline was significantly higher with the 
water-circulating blankets (1.33 ±  0.63°C/h), gel-pads (1.04 ±
0.14°C/h) and intravascular cooling (1.46 ± 0.42°C/h) 
compared to conventional cooling (0.31 ± 0.23°C/h) and the 
air-circulating blankets (0.18 ±  0.2°C/h) (p <  0.01). After the 
target temperature was reached, the intravascular cooling 
device was 11.2 ±  18.7% of the time out of range, which was 
significantly less compared to all other methods.
Conclusion Cooling with water-circulating blankets, gel-pads 
and intravascular cooling is more efficient compared to 
conventional cooling and air-circulating blankets. The 
intravascular cooling system is most reliable to maintain a stable 
temperature.
Introduction
Temperature management is used with increasing frequency 
as a tool to mitigate neurological injury. Mild hypothermia has 
a beneficial effect on outcome in patients after out of hospital 
cardiac arrest [1-3]. Hypothermia also effectively lowers 
intracranial pressure in patients after traumatic brain injury [4­
6] and was found to lower mortality in subgroups of patients
[7]. In a Cochrane analysis, however, no overall benefit in 
terms of lower morbidity or mortality could be determined [8].
Fever is extremely common in brain-injured patients. The risk 
increases with the length of ICU stay from 16% for patients 
admitted to a neurological intensive care unit (ICU) for less
ICU =  intensive care unit; SD =  standard deviation.
than 24 hours to 93% for those staying longer than 14 days 
[9]. Hyperthermia exacerbates ischemic neuronal injury in 
patients at risk of secondary brain damage [10].
Temperature reduction is neither easy nor without risk. Induc­
tion of hypothermia can result in decreased cardiac output, 
arrhythmias, bleeding diathesis, electrolyte disorders and 
increased insulin resistance [11]. To be applicable in a larger 
number of patients, cooling has to be accomplished in an 
easy, controllable, minimally invasive and well-tolerated way. 
Little is known about the optimal method of temperature con­
trol. Most studies have compared a single cooling technique 
with medical treatment or another cooling device. The aim of
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this study is to compare five different cooling techniques dur­
ing induction and maintaining of mild hypo- and normothermia 
in terms of efficiency and cooling performance.
Materials and methods
Study population
A total of 50 consecutive adult patients with an indication for 
controlled mild hypothermia or strict normothermia were pro­
spectively enrolled. The local Institutional Review Board 
waived the need for informed consent. The target temperature 
in the mild hypothermia group was a rectal temperature of 
33°C, and in the strict normothermia group the target temper­
ature was a rectal temperature of 37°C.
The study was conducted in the ICU of a tertiary university 
hospital. Patients were eligible for induction of normothermia if 
they developed a temperature of >38.5°C  for at least 30 min­
utes. The ICU medical staff identified the patients that required 
cooling to hypo- or normothermia.
Patients were excluded from the study if they had a rectal tem­
perature <34.5°C  (in the hypothermia group) or <38.5°C  (in 
the normothermia group) at the beginning of the study. In addi­
tion, patients were excluded if they suffered from severe hemo­
dynamic instability, severe sepsis, or active bleeding or if they 
received renal replacement therapy. Severe hemodynamic 
instability was defined as the need for increasing amounts of 
vasoactive support, or requiring >0.5 |ig/kg/minute 
(nor)epinephrine. Severe sepsis was defined as sepsis with 
organ dysfunction/failure. Active bleeding was defined as 
blood loss requiring more than 2 units of erythrocyte concen­
trates/24 hours.
Study intervention
Ten patients in each group were prospectively assigned to 
conventional cooling, cooling with a water circulating external 
cooling device (Blanketrol II, Cincinatti Subzero, The Surgical 
Company, Amersfoort, The Netherlands), an air circulating 
external cooling device (Caircooler CC1000, Medeco, Oud- 
Beijerland, The Netherlands), a water circulating external cool­
ing device using self-adhesive gel-coated pads (Arctic Sun, 
Medivance, Jugenheim, Germany) or an intravascular heat 
exchange system (Icy-catheter, Alsius Coolgard 3000, Medi- 
cor, Nieuwegein, The Netherlands). Randomization was done 
by assignment of the patients in consecutive order to the dif­
ferent devices. Following identification by the medical staff, the 
patients were included in the study and allocated to a cooling 
method. The order of the cooling devices was determined ran­
domly and not influenced by the clinicians responsible for the 
individual patients. During the test period of a specific device, 
no patient was cooled using any other device, unless the 
number of patients in need of temperature management 
exceeded the number of available cooling machines. In that 
case the additional patients were cooled using conventional 
cooling (considered standard cooling in our hospital) and not
included in this study. In each group, five patients were cooled 
to hypothermia and five patients to normothermia.
Conventional cooling consisted of rapid infusion of 30 ml/kg 
ideal bodyweight of lactated Ringer's solution at 4°C, followed 
by surface cooling using ice and/or coldpacks. The timing and 
amount of ice and coldpacks were judged by the attending 
nurse and guided by the patient's temperature.
The water circulating cooling system consists of two water-cir­
culating cooling blankets, placed under and over the patient, 
and a third smaller blanket under the patient's head. The large 
blankets have of 1.1 m2 each, the smaller blanket a surface 
area of 0.15 m2, and all are connected to an automatic temper­
ature control module guided by the rectal temperature of the 
patient. The temperature of the water circulating through the 
blankets ranges between 4°C and 42°C.
The air-circulating cooling system uses a single blanket placed 
over the patient with a total surface area of 1.9 m2. According 
to the manufacturer's manual, air temperature reaching the 
patient is within 2°C of the listed temperatures, with an airflow 
of 28 -3 2  cfm. This blanket cannot be connected to an auto­
matically guided temperature module, and was set manually at 
the lowest temperature possible (that is, 10°C). After the tar­
get temperature was reached, the temperature of the device 
was manually adjusted by the attending nurse (range 10°C to 
42°C).
The gel-coated external cooling device consists of four water 
circulating gel coated energy transfer pads, and is placed on 
the patient's back, abdomen, and both thighs. Depending on 
the size used, the total surface area ranges between 0.60 and 
0.77 m2. It is connected to an automatic thermostat controlling 
the temperature of the circulating water (range 4°C to 42°C) 
based on the patient's rectal temperature.
The intravascular cooling system uses a single lumen (8.5 Fr, 
38 cm) central venous catheter inserted into the inferior vena 
cava via the left or right femoral vein. Normal saline is pumped 
through three balloons mounted on the catheter and returned 
to a central system in a closed loop. The saline flow within the 
balloons is in close contact with the patient's blood flow and 
serves as a heat exchange system. An automatic temperature 
control device adjusts the temperature of the circulating saline 
(range 4°C to 42°C) based on the patient's rectal temperature.
Conventional cooling was the standard method of tempera­
ture control in the ICU. After extensive instruction by the man­
ufacturer, no learning curve was required for the different 
cooling devices. All these cooling devices were used as 
advised by the operator's manual and the distributor. None of 
the commercially available systems were pre-cooled before 
use. Temperature recording to measure cooling rate was 
started when the cooling device was connected to the patient
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and ready for use. In the conventional group, time was started 
at the start of the infusion of cold fluids. If the target tempera­
ture was not reached within 12 hours after start of the cooling, 
ice and cold packs were used for additional cooling. No alter­
native cooling was used in the patients allocated to conven­
tional cooling.
Standard care
All patients were admitted to the ICU, monitored and treated 
according to international standards. All patients were intu­
bated and mechanically ventilated. If necessary, patients were 
sedated using midazolam and/or propofol to a Ramsay score 
of 6 and received adequate analgesia with morphine or fenta­
nyl. If patients exhibited clinical signs of shivering they were 
treated with extra sedation, morphine or rocuronium as a non­
depolarizing neuromuscular blocking agent. Use of paraceta­
mol was not dictated by protocol, but left to the discretion of 
the attending medical staff. Vasoactive or inotropic support, 
usually norepinephrine or dobutamine was administered if 
necessary.
Data collection
Demographic, clinical, laboratory and pharmacological data 
were obtained through review of the medical records of the 
patients. Body temperature was measured continuously using 
a rectal temperature probe (YSI Incorporated 401, Van de 
Putte Medical, Nieuwegein, The Netherlands) and recorded 
every 15 minutes for at least 24 hours. If the cooling device 
was equipped with a temperature control module, the patients 
received two separate rectal temperature probes, one con­
nected to the central ICU monitoring system, the other con­
nected to the control module of the cooling device.
The primary endpoints of the study were the initial rate of tem­
perature decrease, expressed as °C/h and the percentage of 
time the temperature was out of range during the first 24 hours 
of treatment (defined as more than 0.2°C above or below tar­
get temperature). When the temperature was out of range, the 
mean temperature change from target was calculated. If the 
target temperature was not reached within 24 hours, treat­
ment was considered as a failure.
Secondary endpoints of the study included occurrence of 
overshoot cooling (defined as a temperature drop >0.5°C  
below target temperature), incidence of hypotension (defined 
as mean arterial pressure <60  mmHg) or arrhythmia, develop­
ment of skin lesions, and malfunction of the cooling device. 
Infections were diagnosed using CDC criteria.
Statistical analysis
Power calculation was based on previous tests using the 
water-circulating cooling device and conventional cooling with 
ice and coldpacks. We considered a 20% difference in cool­
ing rate as clinically important. W ith an estimated standard 
deviation (SD) of 15% and a significance level a  of 0.05, a
sample size of 5 patients per group was calculated to reach a 
power of 90%. We therefore included ten patients per group 
in the present study (five patients in the hypothermia group 
and five in the normothermia group). Rates of temperature 
decline over time were analyzed with one-way analysis of vari­
ance. Differences between groups were analyzed with one­
way analysis of variance, with Bonferroni correction for multi­
ple comparisons or by Chi square test as appropriate. A p <  
0.05 was considered statistically significant. All data are 
expressed as mean ±  SD unless otherwise stated.
Results
Baseline characteristics
A total of 50 patients were enrolled in the study. The clinical 
and demographic characteristics of the patients at randomiza­
tion are shown in Table 1. No differences were found with 
respect to age, body mass index, or APACHE II scores. The 
majority of the patients treated with mild hypothermia were 
patients after out-of-hospital arrest with a presumed cardiac 
origin (Table 1). Other indications for hypothermia included in- 
hospital-arrest, and uncontrollable intracranial pressure after 
traumatic brain injury. The majority of the patients enrolled in 
the normothermia group had subarachnoid hemorrhage or 
traumatic brain injury (Table 1). Fever was most frequently of 
infectious origin with pneumonia as the most frequent identi­
fied cause.
Induction of hypo- and normothermia
In the hypothermia group, the speed of cooling (expressed as 
°C/h) was significantly higher in the patients cooled with the 
water-circulating cooling device (1.33 ±  0.63°C/h), the gel- 
coated external device (1.04 ±  0.14°C/h) and the intravascu­
lar catheter (1.46 ±  0.42°C/h) compared to both the air-circu­
lating cooling device (0.18 ±  0.20°C/h) and conventional 
cooling (0.32 ±  0.24°C/h) (p <  0.05) (Figure 1). Similar results 
were found in the normothermia group, with a mean tempera­
ture decrease of 1.12 ±  0.46°C/h in patients cooled with the 
water-circulating cooling device, 1.02 ±  0.71°C/h with the gel- 
coated device and 1.02 ±  0.55°C/h with the intravascular 
catheter compared to both 0.15 ±  0.10°C/h with the air-circu­
lating cooling device and 0.06 ±  0.05°C/h with conventional 
cooling (p <  0.05; Figure 1).
Additional cooling with ice and cold packs was necessary in 
two patients in both the hypothermia and normothermia 
groups cooled with the air-circulating cooling device (Table 2). 
Treatment failure, defined as failure to reach the target temper­
ature within 24 hours after start of cooling, occurred in 2 hypo­
thermia patients with conventional cooling, 2 hypothermia 
patients cooled with the air-circulating device, 4 normothermia 
patients with conventional cooling and 1 normothermia patient 
cooled with the air-circulating device. Use of sedatives and 
analgesics differed (non-statistically) between groups (Table 
2). Five patients were treated without the use of sedation. 
These patients were comatose after cardiac arrest with a
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T a b le  1
B ase line  characteris tics o f pa tien ts  in th e  hypotherm ia and no rm otherm ia  groups
Conventional BR C C AS CG P  value
Hypothermia
Gender (male) 5 4 3 3 4 0.546
Age (years) 69.4 ±  16.3 64 .6  ±  7.8 63 .4 ±  17.6 58 .8  ±  14.7 60 .4 ±  14.6 0 .706
APACHE II 26.8 ±  4.8 29.2 ±  5.2 22.4 ±  9.5 22.0 ±  11.8 26.2 ±  9.3 0 .268
BMI (kg/m2) 26.3 ±  3.4 25.2 ±  1.5 26.0 ±  4.2 26.4 ±  3.8 24.4 ±  3.2 0.137
Diagnosis
OHA 2 4 3 5 2
IHA 2 0 0 0 2
Cardiac origin 2 3 3 3 2
High ICP 1 1 2 0 1
Alive at discharge from ICU 4 1 2 4 0 0.034
Norm otherm ia
Gender (male) 3 4 4 3 5 0.546
Age (years) 46.4 ±  7.3 37 .8 ±  14.7 49 .0 ±  15.4 57 .6  ±  16.2 48 .8 ±  12.8 0.05
APACHE II 20.6 ±  7.9 15.6 ±  8.6 21.2 ±  9.6 24.2 ±  4.1 24.0 ±  7.3 0 .770
BMI (kg/m2) 25.5 ±  0.5 25.9 ±  4.7 25.3 ±  2.8 25.7 ±  1.7 24.9 ±  1.8 0 .868
Diagnosis
SAH 2 0 2 3 1
TBI 2 5 1 1 2
Post-anoxic 0 0 2 0 2
Intracerebral hemorrhage 1 0 0 1 0
Cause of fever
Pneumonia 3 3 3 5 2
Meningitis 1 1 0 0 0
C V C  related bacteriemia 0 1 0 0 2
SIRS 1 0 2 0 1
Alive at discharge from ICU 5 3 0 4 5 0.003
Conventional, conventional cooling with ice cold fluids and ice/coldpacks; BR, water-circulating cooling system; CC, air-circulating cooling 
system; AS, gel-coated cooling system; CG, intravascular cooling system. BMI, body mass index; CVC, central venous catheter; ICP, intracranial 
pressure; ICU, intensive care unit; IHA, in-hospital arrest; OHA, out-of hospital arrest; SAH, sub-arachnoidal hemorrhage; SIRS, systemic 
inflammatory response syndrome; TBI, traumatic brain injury.
Glasgow Coma Score of 3 and showed no signs of discomfort 
or shivering while cooling to hypothermia (two patients) or nor­
mothermia (three patients). In the hypothermia group, neu­
romuscular blocking was necessary in two patients with 
conventional cooling, three patients cooled with the air-circu­
lating and water-circulating systems, five patients cooled with 
the gel-coated cooling device and five patients cooled with the 
intravascular cooling system. In the normothermia group, neu­
romuscular blocking was used in no patients with conventional 
cooling, three patients cooled with the air-circulating and
water-circulating systems, four patients cooled with the gel- 
coated cooling device and five patients cooled with the intra­
vascular cooling system.
Maintaining hypo- and normothermia
After the target temperature was reached, we measured the 
percentage of time the patient's temperature was 0.2°C below 
or above the target temperature. Compared to all other cooling 
methods, the intravascular cooling device was significantly 
more reliable in keeping the patients within the target range
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F ig u re  1
□  Hypothermia 
■  Normothermia
Conventional BR CC AS CG
Induction of hypo- and normothermia. The pace of cooling (expressed 
as°C/h) in the hypothermia and normothermia groups. Bars represent 
mean values ±  standard deviation. Asterisks indicate significant differ­
ences. Conventional, conventional cooling with ice cold fluids and ice/ 
coldpacks; BR, water-circulating cooling system; CC, air-circulating 
cooling system; AS, gel-coated cooling system; CG, intravascular cool­
ing system.
(Figure 2). In the hypothermia group the intravascular catheter 
was 3.2 ±  4.8% of the time out of range compared to 69.8 ±  
37.6% with conventional cooling, 50.5 ±  35.9 with the water- 
circulating cooling device, 74.1 ±  40.5% with the air-circulat­
ing cooling device and 44.2 ±  33.7% with the gel-coated 
external cooling system (p <  0.05). Similar results were found 
in the normothermia group: the intravascular catheter was 4.2 
±  5.1% of the time out of range compared to 97.4 ±  5.8% with 
conventional cooling, 74.8 ±  17.4 with the water-circulating 
cooling device, 53.6 ±  29.5% with the air-circulating cooling 
device and 40.2 ±  19.5% with the gel-coated external cooling 
system (p <  0.05).
Mean temperature deviation from the target temperature in the 
hypothermia group was significantly lower in the patients 
cooled with the intravascular catheter (0.24 ±  0.14°C) 
compared to all other groups: conventional cooling (0.48 ±  
0.3°C), the water-circulating cooling device (0.58 ±  0.47°C), 
the air-circulating cooling device (0.67 ±  0.36°C), and the gel- 
coated external cooling system (0.45 ±  0.42°C) (Figure 3) (p 
<  0.05). Mean temperature deviation from the target tempera­
ture in the normothermia group was significantly lower in 
patients cooled with the intravascular catheter (0.13 ±  
0.06°C) compared to conventional cooling (0.56 ±  0.38°C), 
the water-circulating cooling device (0.66 ±  0.43°C), the air- 
circulating cooling device (0.23 ±  0.18°C), and the gel-coated 
external cooling system (0.31 ±  0.19°C) (Figure 3) (p <  0.05).
Adverse events
In the hypothermia group, a drop of body temperature during 
initiation of cooling of more than 0.5°C below the target 
temperature was found in 1 patient with conventional cooling,
3 patients cooled with the water-circulating cooling device 
and 3 patients with the gel-coated external cooling device. In 
the normothermia group, overshoot was found in three 
patients cooled with the water-circulating cooling device and 
two patients with the gel-coated external cooling device.
Hypotension and arrhythmia were observed only in hypother­
mia patients without differences between the groups (Table 
2). This occurred exclusively in patients after cardiac arrest 
and may have resulted from the underlying condition rather 
than a specific cooling method. The use of inotropic agents 
was comparable between the groups. Hypotension or use of 
inotropic support was not related to speed of cooling or occur­
rence of overshoot cooling. Malfunctioning of a cooling device 
did not occur. Skin lesions or catheter-related events, such as 
thrombosis or infection, were not reported.
Discussion
This is the first study comparing the efficiency and safety of 
five different cooling methods in inducing and maintaining 
hypo- and normothermia in ICU patients. Cooling using water- 
circulating blankets, gel-coated water circulating pads and 
intravascular cooling was equally efficient in inducing hypo- 
and normothermia. Intravascular cooling was superior to all 
other cooling methods for maintaining a stable target temper­
ature. No adverse events related to a specific cooling method 
were documented. The absence of adverse events should, 
however, be interpreted with caution because of low numbers.
In our trial, induction of cooling using water-circulating blan­
kets, water-circulating gel pads or intravascular cooling was 
equally effective. A previous comparison between water-circu­
lating blankets and gel pads in febrile ICU patients found that 
cooling with gel pads was significantly more effective than 
blankets in reducing fever [12]. This may be explained by the 
fact that, in that trial, a single water blanket was used with a 
surface area of only 0.92 m2. We used three water-circulating 
cooling blankets with a total surface area of 2.35 m2. The rate 
of cooling with the gel-pads in our trial is comparable with 
results from previous trials [13,14], indicating that the perform­
ance of this cooling device was similar in our patients. Intravas­
cular cooling was equally effective in inducing the target 
temperature compared to water blankets and gel pads. Previ­
ously, intravascular cooling has been shown to be more effec­
tive than air- and water-circulating blankets in both inducing 
and maintaining hypothermia [15]. External cooling was signif­
icantly less efficient in our trial, possibly explaining the superi­
ority of the endovascular catheter in this study. The superiority 
of endovascular cooling is most likely due to the direct heat- 
exchange between catheter and blood, resulting in a rapid 
transfer of cold blood through the body, whereas surface 
cooling depends on relatively slow conduction of cold mainly 
through the tissue itself. The effectiveness of devices with an 
automatic temperature control module was higher compared 
to manually operated methods. It is unlikely, however, that con-
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T a b le  2
P a tie n t characteris tics during cooling to  hypo- and no rm otherm ia  in th e  hypotherm ia and n o rm otherm ia  groups
Conventional BR C C AS CG P  value
Hypothermia
Sedatives 5 5 3 5 5 0.069
Neuromuscular blockers 2 3 3 5 5 0.129
Analgesics 5 4 3 5 5 0.195
Paracetamol 3 0 3 2 2 0.287
Inotropic agents 5 3 3 2 4 0.311
Vasodilatory agentsa 
Adverse events
0 1 3 0 1 0.112
0.271
Hypotensionb 2 2 1 2 2
Arrhythmiac 0 2 2 3 2
Skin lesions 
Overshootd
0 0 0 0 0
0.058
No. of patients 
Lowest temperature (°C)
1
31.9
3
31 .0 ±  0.3
0 3
32 .4 ±  0.1
0
Use of additional cooling 0 0 2 0 0 0.069
Treatment failuree 2 0 2 0 0 0.129
Norm otherm ia
Sedatives 4 3 5 5 5 0.195
Neuromuscular blockers 0 3 3 4 5 0.195
Analgesics 4 3 5 5 5 0.195
Paracetamol 5 5 4 4 5 0.515
Inotropic agents 1 0 2 3 2 0.311
Vasodilatory agentsa 0 0 1 0 0 0.384
Antibiotics 
Adverse events
4 5 5 5 5 0.384
0.069
Hypotensionb 0 0 1 0 0
Arrhythmiac 0 0 1 0 0
Skin lesions 
Overshootd
0 0 0 0 0
0.040
No. of patients 
Lowest temperature (°C)
0 3
35.7 ±  0.4
0 2
36.1 ±  0.1
0
Use of additional cooling 0 0 2 0 0 0.069
Treatment failuree 4 0 1 0 0 0.019
Conventional, conventional cooling with ice cold fluids and ice/coldpacks; BR, water-circulating cooling system; CC, air-circulating cooling 
system; AS, gel-coated cooling system; CG, intravascular cooling system. aVasodilatation used low dose nitroglycerin or ketanserin iv. 
bHypotension is defined as mean arterial pressure < 60 mmHg. cArrhythmia defined as any rhythm but normal sinus rhythm, sinus bradycardia or 
sinus tachycardia. dOvershoot defined as drop of body temperature during initiation of cooling > 0 .5 °C  below target temperature. eTreatment 
failure defined as failure to reach target temperature within 24 hours after start of cooling.
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Maintaining target temperature. The ability of the cooling device to 
maintain a stable target temperature is depicted as the percentage of 
time the patient's temperature was 0.2°C  below or above the target 
temperature. Bars represent mean values ±  standard deviation. Aster­
isks indicate significant differences. Conventional, conventional cooling 
with ice cold fluids and ice/coldpacks; BR, water-circulating cooling 
system; CC, air-circulating cooling system; AS, gel-coated cooling sys­
tem; CG, intravascular cooling system.
F igure  3
1.2 
1.0 ^
0.8 
P 0.6
0.4  -  
0.2 
0.0
□  Hypothermia 
■  Normothermia
*ík
Conventional BR CC AS CG
Temperature deviation from target temperature. Mean temperature 
deviation after induction of hypothermia or normothermia while main­
taining the target temperature. Bars represent mean values ±  standard 
deviation. Asterisks indicate significant differences. Conventional, con­
ventional cooling with ice cold fluids and ice/coldpacks; BR, water-cir­
culating cooling system; CC, air-circulating cooling system; AS, gel- 
coated cooling system; CG, intravascular cooling system.
trol of temperature fully accounts for the lack of efficiency. At 
the initiation of cooling all devices were set to their maximum 
performance, yet the speed of cooling in the induction phase 
was lower in the manually operated methods. In the case of 
slow or inadequate regulation by the nursing staff, we would 
have expected cases of severe hypothermia, which was not 
the case in this series.
In terms of labour, the methods without an automatic temper­
ature feedback module required constant supervision by the
nursing staff and were most labour intensive. The endovascu­
lar method required the insertion of a central venous line; this 
drawback is relative since most patients in the ICU need cen­
tral venous access under these conditions. The cost of the dif­
ferent devices is mainly determined by the use of the 
disposables. The endovascular cooling system was most 
expensive (approximately 1,000 Euro per patient) followed by 
the gel coated surface cooling (approximately 700 Euro per 
patient), the air circulating device (approximately 25 Euro per 
patient) and the water circulating blanket (approximately 25 
Euro per patient).
Conventional cooling was not effective in our study and 
resulted in treatment failure in 60% of our patients. This is in 
contrast with other studies showing an average temperature 
decrease of 1.7°C to 2.5°C per hour [16-18]. An even higher 
temperature decrease of 4°C in the first hour was found by 
Polderman and colleagues [19], who combined ice-cold fluids 
with a water-circulating cooling device. In our trial, conven­
tional cooling was induced by rapid infusion of 30 ml/kg ideal 
bodyweight of lactated Ringer's solution at 4°C. The speed of 
infusion was not dictated by protocol whereas in the study by 
Polderman and colleagues, 1,500 ml of fluid was infused in 30 
(no cardiac shock) or 60 minutes (cardiac shock). In addition, 
Polderman and colleagues used water circulating blankets in 
addition to the infusion of cold fluids. Application of ice or 
coldpacks may have been less efficient compared to this cool­
ing device. The lack of effectiveness in our study may be the 
result of slower infusion rates, lower volumes, or inadequate 
amounts of ice and coldpacks.
Cooling was less efficient in normothermia compared to hypo­
thermia. At normothermia the body's control mechanisms to 
maintain the centrally mandated target temperature are work­
ing at maximum efficiency. In addition, in hyperthermic 
patients, the central thermostat may be influenced by inflam­
mation, or be deregulated by primary neurological damage. In 
hypothermia the body's re-warming mechanisms are less 
effective, especially when the body temperature drops below 
33°C.
There are several limitations to this study. The nursing staff and 
attending doctors could not be blinded to treatment allocation 
for obvious practical reasons. It is unlikely that this would have 
influenced the outcomes of this study since the cooling 
devices were operated strictly according to the operators' 
manuals, and temperatures were recorded automatically.
The use of sedatives, analgesics and neuromuscular blocking 
agents differed between the groups. These drugs were admin­
istered only in case of shivering and distress, and their pre­
scription was left to the discretion of the attending medical 
staff not involved in this clinical trial. In humans, core tempera­
ture is normally maintained within a tight range. A reference 
temperature (set point) generated by a network of warm, cold,
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and thermal insensitive neurons in the pre-optic area is com­
pared with feedback from the skin and core thermoreceptors. 
An error signal, proportional to the difference between the set 
point and feedback signal, is generated, which activates ther­
moeffector pathways, including vasoconstriction and shiver­
ing. A larger difference between set point and feedback signal 
will thus result in more intense vasoconstriction and shivering. 
This was also the case in our trial: the devices that resulted in 
a stronger decrease of the feedback signal induced shivering 
more frequently. In this study, patients were sedated to a Ram­
say score of 6 and received adequate analgesia with morphine 
or fentanyl. If patients exhibited clinical signs of shivering, they 
were treated with extra sedation, morphine or muscle relaxa­
tion. In our ICU, this is the normal protocol in patients that need 
temperature management. Most studies that compare differ­
ent cooling devices use a similar protocol of sedation and 
relaxation [19-24]. In those studies as well as in our study, 
patients treated with the most efficient cooling device needed 
more sedation and relaxation. Since this was caused by the 
stronger temperature decline in these patients, differences in 
use of sedation and relaxation is considered a consequence 
rather than cause of efficient cooling.
Pulmonary artery core temperature is considered the gold 
standard for measurement of core body temperature [25-28]. 
A major disadvantage is the invasive nature of this technique 
and its relatively high cost. Rectal temperature is comparable 
to pulmonary artery core temperature (mean difference of 0.07 
±  0.4°C) and has a time lag of approximately 15 minutes [29]. 
This technique was chosen because it is common practice in 
most ICUs. In addition, the water-circulating cooling device, 
the gel-coated external cooling system and the endovascular 
cooling system are all equipped with an automatic tempera­
ture control device based on the patient's rectal temperature. 
Previous studies comparing different devices also used non­
invasive temperature measurement. To ensure that the results 
of this study are applicable to most ICUs and comparable to 
previous studies, we chose to measure temperature in a non­
invasive way.
Conclusion
The results of our study demonstrate that water-circulating 
blankets, gel-coated water circulating pads and intravascular 
cooling are equally efficient in inducing hypothermia and nor­
mothermia. For maintaining the target temperature, intravascu- 
lar cooling is superior to all other cooling methods.
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Key messages
• Cooling with water-circulating blankets, gel-pads and 
intravascular cooling is more efficient compared to con­
ventional cooling and air-circulating blankets.
• The intravascular cooling system is most reliable to 
maintain a stable temperature.
• No adverse events related to a specific cooling method 
were documented.
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